Try our Advanced Search for more refined results
Orion Oyj
-
Notice | Filed: May 03, 2024 | Entered: May 03, 2024 Orion Corporation et al v. Hetero USA Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice - Other
NOTICE of SERVICE of Document Production pursuant to Paragraph 4(b) of the Default Standard and Paragraph 1(c) of the Scheduling Order (D.I. 31) by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc. (Cramer, Kristen)
-
Discovery | Filed: April 05, 2024 | Entered: April 05, 2024 Orion Corporation et al v. Hetero USA Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Defendants Hetero USA Inc., Hetero Labs Ltd., Unit-V, and Hetero Labs Ltd. and (2) Plaintiffs' First Set of Requests for Production to Defendants Hetero USA Inc., Hetero Labs Ltd., Unit-V, and Hetero Labs Ltd. - filed by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation.(Fahnestock, Derek)
-
Order | Filed: April 04, 2024 | Entered: April 04, 2024 Orion Corporation et al v. Hetero USA Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
SO ORDERED
SO ORDERED, re 35 Stipulated Protective Order. Signed by Judge Jennifer L. Hall on 4/4/2024. (ceg)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login